Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

W G Powderly

Showing results (111-120 of 128) with videos related to

Pageof 13
Sort By:
Annals of Internal Medicine|January 1, 1995
Combination and monotherapy with zidovudine and zalcitabine in patients with advanced HIV disease. The NIAID AIDS Clinical Trials GroupM A Fischl, K Stanley, A C Collier, et al.
The New England Journal of Medicine|March 16, 1995
A randomized trial of three antipneumocystis agents in patients with advanced human immunodeficiency virus infection. NIAID AIDS Clinical Trials GroupS A Bozzette, D M Finkelstein, S A Spector, et al.
HIV Medicine|February 9, 2008
European AIDS Clinical Society (EACS) guidelines on the prevention and management of metabolic diseases in HIVJ D Lundgren, M Battegay, G Behrens, et al.
Annals of Internal Medicine|May 15, 1992
Blastomycosis in patients with the acquired immunodeficiency syndromeP G Pappas, J C Pottage, W G Powderly, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|August 1, 1995
USPHS/IDSA guidelines for the prevention of opportunistic infections in persons infected with human immunodeficiency virus: an overview. USPHS/IDSA Prevention of Opportunistic Infections Working GroupJ E Kaplan, H Masur, K K Holmes, et al.
Journal of Acquired Immune Deficiency Syndromes|February 1, 1994
The safety and efficacy of combination N-butyl-deoxynojirimycin (SC-48334) and zidovudine in patients with HIV-1 infection and 200-500 CD4 cells/mm3M A Fischl, L Resnick, R Coombs, et al.
Annals of Internal Medicine|May 15, 1990
The safety and efficacy of zidovudine (AZT) in the treatment of subjects with mildly symptomatic human immunodeficiency virus type 1 (HIV) infection. A double-blind, placebo-controlled trial. The AIDS Clinical Trials GroupM A Fischl, D D Richman, N Hansen, et al.
The New England Journal of Medicine|March 19, 1992
A controlled trial of fluconazole or amphotericin B to prevent relapse of cryptococcal meningitis in patients with the acquired immunodeficiency syndrome. The NIAID AIDS Clinical Trials Group and Mycoses Study GroupW G Powderly, M S Saag, G A Cloud, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|May 18, 2000
Refractory mucosal candidiasis in advanced human immunodeficiency virus infectionC J Fichtenbaum, S Koletar, C Yiannoutsos, et al.
The New England Journal of Medicine|January 9, 1992
Comparison of amphotericin B with fluconazole in the treatment of acute AIDS-associated cryptococcal meningitis. The NIAID Mycoses Study Group and the AIDS Clinical Trials GroupM S Saag, W G Powderly, G A Cloud, et al.
Pageof 13

Showing results (111-120 of 128) with videos related to

Sort By:
Pageof 13
Annals of Internal Medicine|January 1, 1995
Combination and monotherapy with zidovudine and zalcitabine in patients with advanced HIV disease. The NIAID AIDS Clinical Trials GroupM A Fischl, K Stanley, A C Collier, et al.
The New England Journal of Medicine|March 16, 1995
A randomized trial of three antipneumocystis agents in patients with advanced human immunodeficiency virus infection. NIAID AIDS Clinical Trials GroupS A Bozzette, D M Finkelstein, S A Spector, et al.
HIV Medicine|February 9, 2008
European AIDS Clinical Society (EACS) guidelines on the prevention and management of metabolic diseases in HIVJ D Lundgren, M Battegay, G Behrens, et al.
Annals of Internal Medicine|May 15, 1992
Blastomycosis in patients with the acquired immunodeficiency syndromeP G Pappas, J C Pottage, W G Powderly, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|August 1, 1995
USPHS/IDSA guidelines for the prevention of opportunistic infections in persons infected with human immunodeficiency virus: an overview. USPHS/IDSA Prevention of Opportunistic Infections Working GroupJ E Kaplan, H Masur, K K Holmes, et al.
Journal of Acquired Immune Deficiency Syndromes|February 1, 1994
The safety and efficacy of combination N-butyl-deoxynojirimycin (SC-48334) and zidovudine in patients with HIV-1 infection and 200-500 CD4 cells/mm3M A Fischl, L Resnick, R Coombs, et al.
Annals of Internal Medicine|May 15, 1990
The safety and efficacy of zidovudine (AZT) in the treatment of subjects with mildly symptomatic human immunodeficiency virus type 1 (HIV) infection. A double-blind, placebo-controlled trial. The AIDS Clinical Trials GroupM A Fischl, D D Richman, N Hansen, et al.
The New England Journal of Medicine|March 19, 1992
A controlled trial of fluconazole or amphotericin B to prevent relapse of cryptococcal meningitis in patients with the acquired immunodeficiency syndrome. The NIAID AIDS Clinical Trials Group and Mycoses Study GroupW G Powderly, M S Saag, G A Cloud, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|May 18, 2000
Refractory mucosal candidiasis in advanced human immunodeficiency virus infectionC J Fichtenbaum, S Koletar, C Yiannoutsos, et al.
The New England Journal of Medicine|January 9, 1992
Comparison of amphotericin B with fluconazole in the treatment of acute AIDS-associated cryptococcal meningitis. The NIAID Mycoses Study Group and the AIDS Clinical Trials GroupM S Saag, W G Powderly, G A Cloud, et al.
Pageof 13